구조적 심질환용 기기 시장 규모는 2022년 109억 7,000만 달러, 예측 기간(2024-2031년) 동안 9.4%의 연평균 복합 성장률(CAGR)로 2023년 119억 7,000만 달러에서 2031년 245억 8,000만 달러로 성장할 것으로 예상됩니다.
세계 구조적 심질환용 기기 시장은 구조적 심장 질환의 발생률 증가, 최소 침습 수술 기술의 발전, 고령화 인구 증가 등 몇 가지 주요 요인으로 인해 강력한 성장세를 보이고 있습니다. 심혈관 질환의 유병률이 증가함에 따라 구조적 심질환용 기기에 대한 수요가 증가하고 있으며, 이는 혁신적인 치료 옵션의 채택을 더욱 촉진하고 있습니다. 이 시장은 기술적으로 진보된 기기에 대한 강력한 지원과 연구개발에 대한 막대한 투자로 뒷받침되고 있으며, 이는 이 분야에서 기술 혁신의 중요성을 강조하고 있습니다. 그러나 이러한 장비의 높은 비용과 까다로운 규제 장벽은 성장에 걸림돌이 될 수 있습니다. 이러한 장애물에도 불구하고, 심장 구조 치료 기기 기술의 지속적인 발전과 순환기 내과에서 환자 중심 치료에 대한 관심이 높아짐에 따라 시장은 상승세를 유지할 것으로 예상됩니다. 특히 미국의 구조적 심질환용 기기 시장은 지속적인 성장을 기대할 수 있는 위치에 있으며, 향후 예측 기간 동안에도 안정적인 연평균 성장률(CAGR)을 보일 것으로 예상됩니다. 이러한 추세는 구조적 심장 질환 영역에서 치료 옵션을 강화하고 첨단 기술 솔루션을 통해 환자 결과를 개선하려는 헬스케어 업계의 노력을 강조하고 있습니다.
Structural Heart Devices Market size was valued at USD 10.97 billion in 2022 and is poised to grow from USD 11.97 billion in 2023 to USD 24.58 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031)
The global structural heart devices market is experiencing robust growth, fueled by several key factors, including the rising incidence of structural heart diseases, advancements in minimally invasive surgical techniques, and an expanding aging demographic. As the prevalence of cardiovascular conditions escalates, the demand for structural heart devices continues to increase, further driving the adoption of innovative treatment options. The market is bolstered by a strong push for technologically advanced devices and significant investments in research and development, highlighting the importance of innovation in this sector. However, challenges such as the high costs of these devices and strict regulatory hurdles could hinder growth. Despite these obstacles, the market is anticipated to maintain its upward trajectory, supported by continuous advancements in structural heart device technology and a heightened focus on patient-centered care within cardiology. In particular, the U.S. structural heart devices market is well-positioned for sustainable growth, with expectations for a steady compound annual growth rate (CAGR) in the upcoming forecast period. This trend underscores the healthcare industry's commitment to improving patient outcomes through enhanced treatment options and cutting-edge technological solutions in the realm of structural heart diseases.
Top-down and bottom-up approaches were used to estimate and validate the size of the Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Structural Heart Devices Market Segmental Analysis
Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Structural Heart Devices Market
The global structural heart devices market is significantly driven by the rising prevalence of structural heart diseases, including heart valve disorders and congenital abnormalities, which necessitate advanced treatment options. As the incidence of these conditions escalates, the demand for specialized devices has surged. Furthermore, technological advancements in minimally invasive procedures have enhanced patient outcomes, making treatments more accessible and effective. Coupled with the increasing geriatric population, which is particularly vulnerable to these ailments, the market continues to expand. This growing demographic shift and innovation in medical devices create a robust environment for the structural heart devices market's growth and evolution.
Restraints in the Structural Heart Devices Market
The global structural heart devices market faces a significant restraint due to the high costs associated with these advanced medical devices and their implantation procedures. The expense encompasses not only the devices themselves but also the comprehensive costs of development, clinical trials, and adherence to regulatory standards, which can place a financial strain on both patients and healthcare systems. In particular, developing regions may experience limited accessibility and affordability, further curtailing market penetration. Additionally, price sensitivity among consumers and restricted insurance coverage in certain markets can impede the widespread adoption of structural heart devices, ultimately stunting the overall growth of the market.
Market Trends of the Structural Heart Devices Market
A prominent trend in the global structural heart devices market is the surge in minimally invasive procedures, exemplified by transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). These innovative techniques are increasingly favored for their substantial advantages, including shorter hospital stays, expedited recovery times, and diminished complications compared to conventional open-heart surgeries. This growth is propelled by continuous advancements in medical technology that enhance procedural precision and efficacy. As healthcare providers and patients alike recognize the benefits of these less invasive options, the demand for structural heart devices is expected to rise steadily, shaping the market's future landscape.